| Ticker | Company  | Zen Rating  | Financials  | Market Cap  | ROE  | ROA  | ROCE  | ROIC  | D/E  | Current Ratio  | Gross Margin  | Profit Margin  | Operating Margin  | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDXG | MIMEDX GROUP INC  | $1.13B | 19.20% | 14.30% | 20.39% | 49.90% | 0.34 | 4.41 | 82.00% | 10.40% | 13.54% | ||
| INCY | INCYTE CORP  | $18.35B | 29.80% | 20.40% | 31.86% | 76.00% | 0.36 | 3.20 | 92.90% | 24.70% | 33.05% | ||
| TBPH | THERAVANCE BIOPHARMA INC  | $738.30M | 6.90% | 3.50% | 11.49% | 15.90% | 0.90 | 6.71 | 100.00% | 16.90% | 55.25% | ||
| AUPH | AURINIA PHARMACEUTICALS INC  | $1.73B | 16.70% | 11.50% | 15.80% | 14.50% | 0.50 | 5.23 | 89.50% | 23.30% | 25.77% | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC  | $1.54B | N/A | -7.40% | 22.20% | 6.00% | -2.08 | 2.25 | 97.00% | -6.40% | 11.15% | ||
| RIGL | RIGEL PHARMACEUTICALS INC  | $566.46M | 438.90% | 57.00% | 88.99% | 124.70% | 1.52 | 2.02 | 91.50% | 36.50% | 39.89% | ||
| ONC | BEONE MEDICINES LTD  | $34.20B | -5.10% | -3.00% | -2.23% | -4.10% | 0.67 | 1.95 | 85.50% | -3.90% | -1.99% | ||
| HALO | HALOZYME THERAPEUTICS INC  | $7.63B | 136.60% | 26.40% | 36.99% | 27.90% | 5.17 | 8.36 | 84.20% | 47.30% | 60.25% | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC  | $3.10B | -29.70% | -12.50% | -10.57% | -9.70% | 1.35 | 3.50 | 90.00% | -13.90% | -9.02% | ||
| PBYI | PUMA BIOTECHNOLOGY INC  | $253.15M | 49.30% | 18.20% | 39.47% | 61.20% | 1.02 | 1.53 | 72.40% | 16.40% | 18.58% | ||
| AKBA | AKEBIA THERAPEUTICS INC  | $580.43M | N/A | -18.90% | -9.98% | -30.20% | 11.62 | 2.23 | 68.00% | -24.50% | -11.82% | ||
| INVA | INNOVIVA INC  | $1.15B | 5.70% | 3.00% | 7.86% | 9.00% | 0.87 | 2.64 | 86.60% | 10.40% | 23.09% | ||
| MIRM | MIRUM PHARMACEUTICALS INC  | $3.65B | -24.80% | -8.50% | -7.40% | -10.50% | 1.85 | 3.13 | 79.00% | -13.60% | -10.02% | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC  | $1.57B | N/A | -9.90% | -2.16% | -1.70% | -18.34 | 1.95 | 82.20% | -13.00% | -2.10% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC  | $60.25B | 26.10% | 1.00% | 3.95% | 2.60% | 19.74 | 2.54 | 83.90% | 1.40% | 4.06% | ||
| ZYME | ZYMEWORKS INC  | $1.33B | -31.60% | -24.00% | -29.74% | -33.70% | 0.31 | 4.71 | 100.00% | -121.70% | -114.77% | ||
| GMAB | GENMAB A  | $18.35B | 24.70% | 19.90% | 30.06% | 75.00% | 0.22 | 6.22 | 94.40% | 37.60% | 52.88% | ||
| TVTX | TRAVERE THERAPEUTICS INC  | $3.15B | -178.70% | -15.80% | -19.15% | -13.30% | 6.32 | 2.75 | 97.60% | -20.30% | -17.73% | ||
| CRMD | CORMEDIX INC  | $754.89M | 22.60% | 17.00% | 14.95% | 53.00% | 0.30 | 4.21 | 95.20% | 20.80% | 20.85% | ||
| NAGE | NIAGEN BIOSCIENCE INC  | $601.34M | 35.50% | 23.80% | 26.49% | 199.80% | 0.43 | 3.88 | 63.60% | 15.20% | 15.76% | ||
| VRTX | VERTEX PHARMACEUTICALS INC  | $109.11B | 22.10% | 15.90% | 22.07% | 31.10% | 0.40 | 2.52 | 86.10% | 31.90% | 38.45% | ||
| ARGX | ARGENX SE  | $49.96B | 24.70% | 21.40% | 10.88% | 20.20% | 0.18 | 5.60 | -19,733.10% | 78,552.00% | 40,946.87% | ||
| XOMA | XOMA ROYALTY CORP  | $398.65M | -15.30% | -5.60% | -2.21% | -2.40% | 1.81 | 4.88 | 100.00% | -27.60% | -9.92% | ||
| FOLD | AMICUS THERAPEUTICS INC  | $2.78B | -19.80% | -4.80% | 3.89% | 3.80% | 2.99 | 3.21 | 90.40% | -6.70% | 4.41% | ||
| LGND | LIGAND PHARMACEUTICALS INC  | $3.75B | -9.20% | -8.10% | -9.15% | -17.30% | 0.15 | 5.45 | 93.00% | -40.40% | -43.10% | ||
| ABUS | ARBUTUS BIOPHARMA CORP  | $906.73M | -59.20% | -44.10% | -55.10% | -68.90% | 0.25 | 20.53 | 100.00% | -351.90% | -351.17% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC  | $2.81B | 7.50% | 5.60% | 8.26% | 14.10% | 0.33 | 3.85 | 87.50% | 6.00% | 8.13% | ||
| ASND | ASCENDIS PHARMA A  | $12.24B | N/A | -33.40% | -107.48% | -42.00% | -6.59 | 1.04 | 85.30% | -92.70% | -51.29% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC  | $1.64B | 26.30% | 17.70% | 25.99% | 53.80% | 0.43 | 3.84 | 78.30% | 23.40% | 31.22% | ||
| VCYT | VERACYTE INC  | $2.83B | 2.80% | 2.60% | 2.83% | 23.70% | 0.10 | 5.10 | 68.00% | 7.10% | 7.57% | ||
| LXRX | LEXICON PHARMACEUTICALS INC  | $501.49M | -83.60% | -42.20% | -56.64% | -49.10% | 0.74 | 4.17 | 99.20% | -206.40% | -184.91% | ||
| FBIO | FORTRESS BIOTECH INC  | $76.17M | -87.40% | -15.80% | -0.19% | -0.40% | 2.79 | 1.92 | 70.90% | -40.60% | -0.34% | ||
| REGN | REGENERON PHARMACEUTICALS INC  | $68.50B | 15.30% | 11.90% | 14.51% | 15.50% | 0.30 | 4.06 | 85.40% | 32.10% | 36.41% | ||
| DOMH | DOMINARI HOLDINGS INC  | $78.28M | -36.60% | -30.20% | -20.49% | -35.90% | 0.24 | 3.65 | 100.00% | -36.00% | -36.01% | ||
| FENC | FENNEC PHARMACEUTICALS INC  | $228.22M | N/A | -24.70% | -23.30% | -24.30% | -7.01 | 4.85 | 89.90% | -36.10% | -25.51% | ||
| EXEL | EXELIXIS INC  | $10.41B | 27.70% | 21.10% | 33.12% | 32.40% | 0.32 | 3.51 | 96.60% | 27.00% | 34.78% | ||
| CPRX | CATALYST PHARMACEUTICALS INC  | $2.60B | 27.50% | 23.80% | 31.66% | 413.50% | 0.14 | 6.71 | 85.80% | 37.40% | 48.70% | ||
| RPRX | ROYALTY PHARMA PLC  | $21.89B | 10.20% | 5.70% | 7.52% | 5.50% | 0.93 | 1.26 | 100.00% | 44.30% | 55.83% | ||
| VALN | VALNEVA SE  | $752.71M | -35.30% | -13.60% | -11.90% | -10.30% | 1.54 | 2.27 | 49.00% | -34.10% | -21.03% | ||
| ZVRA | ZEVRA THERAPEUTICS INC  | $571.46M | 4.00% | 1.30% | 13.14% | 23.30% | 1.19 | 7.85 | 72.00% | 4.30% | 48.18% | ||
| INBX | INHIBRX BIOSCIENCES INC  | $1.18B | -137.80% | -76.30% | -91.16% | -390.10% | 2.09 | 4.98 | 100.00% | -11,692.40% | -11,275.86% | ||
| FTRE | FORTREA HOLDINGS INC  | $941.40M | -95.00% | -31.10% | -49.46% | -65.70% | 3.81 | 1.02 | 19.70% | -37.60% | -34.25% | ||
| SLGL | SOL-GEL TECHNOLOGIES LTD  | $96.11M | -10.20% | -8.40% | -9.93% | -14.20% | 0.23 | 7.32 | 100.00% | -14.20% | -14.25% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP  | $2.64B | -60.90% | -23.00% | -27.07% | -22.50% | 1.76 | 2.84 | 66.00% | -59.10% | -53.35% | ||
| ATRA | ATARA BIOTHERAPEUTICS INC  | $104.29M | -8.30% | 6.60% | 44.55% | 25.20% | -2.05 | 1.70 | 81.20% | 3.10% | 5.27% | ||
| CORT | CORCEPT THERAPEUTICS INC  | $7.74B | 20.00% | 16.10% | 15.26% | 17.50% | 0.26 | 3.06 | 98.40% | 18.40% | 14.00% | ||
| FHTX | FOGHORN THERAPEUTICS INC  | $249.30M | N/A | -28.00% | -50.79% | -44.10% | -3.95 | 2.62 | 100.00% | -311.90% | -311.90% | ||
| SPRO | SPERO THERAPEUTICS INC  | $136.75M | -120.30% | -55.60% | -113.62% | -424.60% | 0.89 | 3.98 | 100.00% | -110.30% | -110.34% | ||
| MESO | MESOBLAST LTD  | $2.13B | -19.00% | -14.10% | -11.56% | -103.10% | 0.31 | 1.99 | 70.20% | -593.90% | -458.45% | ||
| OVID | OVID THERAPEUTICS INC  | $98.84M | -58.80% | -43.20% | -55.73% | -55.70% | 0.39 | 4.72 | 100.00% | -574.00% | -574.02% | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC  | $188.97M | 14.70% | 8.70% | 16.88% | 29.10% | 0.57 | 2.72 | 57.50% | 10.10% | 14.82% | ||
| VCEL | VERICEL CORP  | $1.77B | 2.50% | 1.70% | 2.00% | 2.00% | 0.42 | 4.97 | 73.50% | 2.90% | 3.16% | ||
| ORMP | ORAMED PHARMACEUTICALS INC  | $98.00M | -16.20% | -15.40% | -22.17% | -33.00% | 0.05 | 26.82 | 0.60% | -1,210.90% | -1,750.95% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC  | $10.29B | 8.80% | 7.10% | 10.12% | 12.20% | 0.26 | 4.83 | 81.30% | 16.80% | 22.30% | ||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC  | $187.76M | N/A | N/A | N/A | N/A | -1.25 | 0.11 | N/A | N/A | N/A | ||
| EVAX | EVAXION A  | $36.32M | -320.20% | -63.60% | -59.92% | -74.40% | 2.61 | 3.42 | 100.00% | -377.00% | -323.11% | ||
| ARDX | ARDELYX INC  | $1.47B | -36.90% | -12.60% | -9.25% | -7.50% | 2.15 | 4.41 | 88.20% | -14.20% | -9.35% | ||
| UTHR | UNITED THERAPEUTICS CORP  | $19.18B | 18.80% | 16.80% | 24.85% | 31.70% | 0.12 | 6.40 | 88.60% | 40.70% | 54.04% | ||
| IRD | OPUS GENETICS INC  | $137.79M | -366.70% | -142.10% | -315.46% | 614.70% | 1.21 | 1.90 | 100.00% | -377.90% | -377.89% | ||
| XNCR | XENCOR INC  | $1.05B | -25.70% | -18.40% | -17.20% | -13.80% | 0.42 | 5.34 | 100.00% | -116.40% | -91.72% | ||
| RLAY | RELAY THERAPEUTICS INC  | $1.22B | -44.20% | -39.50% | -43.73% | -46.50% | 0.11 | 19.96 | 100.00% | -4,341.50% | -4,341.53% | ||
| ACAD | ACADIA PHARMACEUTICALS INC  | $3.80B | 35.30% | 21.70% | 31.92% | 64.00% | 0.48 | 2.88 | 92.00% | 23.00% | 26.58% | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC  | $8.35B | -10.00% | -3.50% | -3.40% | -4.00% | 1.95 | 1.62 | 88.70% | -9.90% | -7.37% | ||
| KRYS | KRYSTAL BIOTECH INC  | $5.72B | 15.20% | 13.80% | 16.05% | 26.50% | 0.09 | 9.68 | 93.40% | 40.80% | 46.98% | ||
| TGTX | TG THERAPEUTICS INC  | $5.52B | 26.10% | 9.60% | 18.37% | 16.60% | 1.54 | 3.86 | 87.00% | 13.30% | 21.47% | ||
| IMCR | IMMUNOCORE HOLDINGS PLC  | $1.66B | -5.90% | -2.10% | -0.47% | -0.50% | 1.72 | 6.36 | 99.00% | -6.50% | -1.24% | ||
| MDGL | MADRIGAL PHARMACEUTICALS INC  | $9.34B | -38.40% | -27.30% | -32.75% | -34.00% | 0.46 | 5.11 | 96.30% | -54.70% | -52.01% | ||
| SRPT | SAREPTA THERAPEUTICS INC  | $2.35B | -4.40% | -1.60% | -0.87% | -0.60% | 1.71 | 2.89 | 79.30% | -2.30% | -0.97% | ||
| NBTX | NANOBIOTIX SA  | $1.01B | N/A | -78.30% | 217.34% | -442.80% | -1.66 | 0.63 | 100.00% | -508.40% | -382.20% | ||
| PTCT | PTC THERAPEUTICS INC  | $5.41B | -71.70% | 29.30% | 39.40% | 123.50% | -15.30 | 3.89 | 96.90% | 33.60% | 45.78% | ||
| CYTK | CYTOKINETICS INC  | $7.59B | N/A | -43.70% | -52.14% | -29.40% | -5.75 | 5.99 | 100.00% | -3,201.50% | -2,996.11% | ||
| BNTX | BIONTECH SE  | $24.98B | -1.80% | -1.60% | -1.65% | -3.50% | 0.17 | 8.61 | 79.80% | -12.00% | -11.35% | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC  | $220.06M | 4.70% | 3.50% | 3.19% | 5.20% | 0.25 | 9.24 | 100.00% | 7.30% | 7.27% | ||
| ASMB | ASSEMBLY BIOSCIENCES INC  | $238.22M | -149.00% | -39.00% | -116.58% | -139.30% | 3.46 | 1.64 | N/A | N/A | N/A | ||
| SLNO | SOLENO THERAPEUTICS INC  | $3.57B | -73.70% | -56.70% | -57.20% | -67.90% | 0.38 | 15.13 | 97.90% | -554.50% | -545.40% | ||
| ENTA | ENANTA PHARMACEUTICALS INC  | $234.30M | -89.00% | -27.30% | -33.61% | -29.90% | 2.80 | 5.00 | 100.00% | -142.00% | -133.00% | ||
| NAMS | NEWAMSTERDAM PHARMA CO NV  | $4.27B | -24.60% | -22.60% | -21.28% | -324.10% | 0.05 | 21.09 | 100.00% | -258.90% | -258.91% | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD  | $16.46M | -94.70% | -76.50% | -121.93% | -192.10% | 0.15 | 7.42 | N/A | N/A | N/A | ||
| AXSM | AXSOME THERAPEUTICS INC  | $6.74B | -357.60% | -41.70% | -80.39% | -140.30% | 7.76 | 1.57 | 91.50% | -49.90% | -48.34% | ||
| TECH | BIO-TECHNE CORP  | $9.73B | 3.60% | 2.80% | 4.49% | 8.10% | 0.33 | 3.46 | 64.80% | 6.00% | 8.77% | ||
| NVO | NOVO NORDISK A S  | $220.84B | 77.90% | 24.20% | 51.26% | 67.90% | 1.87 | 0.78 | 83.90% | 35.60% | 45.13% | ||
| TRAW | TRAWS PHARMA INC  | $18.15M | -1,812.50% | 512.70% | 1,063.00% | -1,416.90% | 0.89 | 2.09 | 100.00% | 3,028.20% | 3,028.25% | ||
| TARS | TARSUS PHARMACEUTICALS INC  | $2.90B | -32.40% | -21.00% | -20.45% | -29.10% | 0.49 | 5.26 | 93.40% | -31.10% | -28.01% | ||
| OKYO | OKYO PHARMA LTD  | $103.05M | N/A | -180.40% | 127.79% | 102.70% | -1.66 | 0.40 | N/A | N/A | N/A | ||
| PTHS | PELTHOS THERAPEUTICS INC  | $100.39M | N/A | -689.50% | 131.48% | 454.90% | -1.13 | 0.11 | N/A | N/A | N/A | ||
| ANAB | ANAPTYSBIO INC  | $1.02B | -367.00% | -30.60% | -44.21% | -20.90% | -8.49 | 8.22 | 100.00% | -107.70% | -107.59% | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC  | $5.86B | -41.10% | -11.60% | -5.41% | -3.60% | 1.65 | 4.87 | 100.00% | -25.90% | -11.19% | ||
| GYRE | GYRE THERAPEUTICS INC  | $746.43M | 5.80% | 3.10% | 5.16% | 7.40% | 0.25 | 5.40 | 95.90% | 4.10% | 6.85% | ||
| QURE | UNIQURE NV  | $3.71B | -1,010.70% | -33.30% | -24.83% | -18.20% | -147.11 | 9.98 | 82.60% | -1,388.00% | -942.05% | ||
| ABEO | ABEONA THERAPEUTICS INC  | $246.65M | 77.70% | 39.80% | 36.32% | 85.00% | 0.51 | 6.73 | 100.00% | 14,310.50% | 19,223.25% | ||
| IMNM | IMMUNOME INC  | $1.40B | -87.40% | -74.80% | -77.68% | -279.60% | 0.10 | 12.13 | 100.00% | -1,687.10% | -1,687.08% | ||
| TSHA | TAYSHA GENE THERAPIES INC  | $1.35B | -79.90% | -45.70% | -30.08% | -175.00% | 0.34 | 12.48 | 100.00% | -1,145.00% | -1,143.96% | ||
| TCRX | TSCAN THERAPEUTICS INC  | $110.09M | -63.80% | -40.50% | -50.02% | -56.20% | 0.69 | 7.06 | 100.00% | -1,964.90% | -1,920.20% | ||
| APLS | APELLIS PHARMACEUTICALS INC  | $2.72B | 18.90% | 5.00% | 11.77% | 12.30% | 1.64 | 3.54 | 88.80% | 4.40% | 9.02% | ||
| VRCA | VERRICA PHARMACEUTICALS INC  | $34.10M | N/A | -115.50% | -400.01% | -132.00% | -3.24 | 1.26 | 86.50% | -330.50% | -268.91% | ||
| ADMA | ADMA BIOLOGICS INC  | $3.69B | 61.80% | 42.90% | 32.10% | 37.00% | 0.40 | 5.33 | 53.00% | 44.10% | 32.73% | ||
| STOK | STOKE THERAPEUTICS INC  | $1.65B | 18.30% | 15.50% | 11.73% | 30.70% | 0.15 | 6.98 | 100.00% | 26.30% | 20.30% | ||
| PGEN | PRECIGEN INC  | $1.23B | -1,156.80% | -108.40% | -158.28% | -224.80% | -2.93 | 2.71 | -0.70% | -2,868.70% | -2,870.25% | ||
| BBIO | BRIDGEBIO PHARMA INC  | $12.07B | N/A | -82.20% | -86.24% | -30.80% | -1.51 | 3.88 | 95.80% | -225.30% | -190.53% | ||
| NBY | NOVABAY PHARMACEUTICALS INC  | $6.70M | 81.70% | 38.50% | 69.73% | 322.00% | 0.63 | 2.85 | 65.20% | 48.80% | 69.98% |